Schroll Medical ApS: Financial statements 2020
CVR: 39467135
Source: annual report 2020, Danish Business Authority
01/10/2019 – 30/09/2020
Schroll Medical ApS (CVR 39467135) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -31,366 and a net result of DKK -2,022,466. Equity in the 2020 report amounted to DKK 27,829,777. The solvency ratio was 62.8%. The company had 25 employees in the financial year.
- Gross Profit
- DKK -31,366
- Profit/Loss
- DKK -2,022,466
- Equity
- DKK 27,829,777
- Total Assets
- DKK 44,290,152
- Employees
- 25
Official annual report
How creditworthy is Schroll Medical ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Schroll Medical ApS has published its interim report for the period April 6, 2018 to September 30, 2019.
About Schroll Medical ApS
Schroll Medical ApS is a Danish company of the type Anpartsselskab based in Årslev, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Carsten Garbo Schroll. The board consists of Søren Dolleris Schroll (chair), Carsten Garbo Schroll, Mariolla Pernille Damborg Dolleris Schroll and Stine Garbo Schroll. The company is owned by Schroll Medical Holding ApS. The company has 107 employees (2026). In 2025, the company reported a gross profit of DKK 98,362,345 and a net result of DKK 40,261,512 compared with DKK 7,271,419 the year before. Equity in the 2025 report amounted to DKK 119,466,113.